Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-09-17

Clinical Trial Update: The Efficacy of PAP Therapy on Reducing AF Recurrence in Patients With Morbidity of OSA [NA]

View source ↗

Summary

A clinical trial evaluating PAP therapy to reduce atrial fibrillation recurrence in patients with obstructive sleep apnea has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PAP therapy (continuous positive airway pressure)

Snippet

Sponsor: Philips (China) Investment CO., LTD | Conditions: Atrial Fibrillation, Obstructive Sleep Apnea | NA | Status: TERMINATED